BayerAG

News

Reuters - 2 days ago

Companies ask US judiciary group to force lawsuit funding disclosures

UPDATE 1-Companies ask US judiciary group to force lawsuit funding disclosures Adds comment in paragraphs 11, 12 from funding advocate By Mike Scarcella Oct 3 (Reuters) - More than 100 major companies from the technology, pharmaceutical, automotive and other sectors have urged the U.S. judiciary to adopt a nationwide rule requiring disclosure of third-party litigation funding in lawsuits.

Reuters - 2 days ago

Companies ask US judiciary group to force lawsuit funding disclosures

Reuters - 2 days ago

Companies ask US judiciary group to force lawsuit funding disclosures

Companies ask US judiciary group to force lawsuit funding disclosures By Mike Scarcella Oct 3 (Reuters) - More than 100 major companies from the technology, pharmaceutical, automotive and other sectors have urged the U.S. judiciary to adopt a nationwide rule requiring disclosure of third-party litigation funding in lawsuits. Companies including Amazon.com, Google, Cisco, Meta, Comcast, Exxon, Zurich, Eli Lilly, Bayer, Ford, Pfizer and Novartis submitted the letter on Wednesday to the federal cou

Reuters - 2 days ago

Bayer sees Intacta2 Xtend GMO seed covering 30% of Brazil's soybeans

Bayer sees Intacta2 Xtend GMO seed covering 30% of Brazil's soybeans SAO PAULO, Oct 3 (Reuters) - Germany's Bayer BAYGn.DE forecasts that some 30% of Brazil's soybean area will be sowed with its genetically modified biotech seed Intacta2 Xtend in the 2024/25 season, doubling the share from the previous crop, a top executive said this week. The exact share Intacta2 Xtend will reach should be clear only in some two or three weeks after expected rains allow a broad planting in Brazil's soy fields,

Reuters - 2 days ago

India's Shivalik Rasayan climbs on US FDA approval for facility

BUZZ-India's Shivalik Rasayan climbs on US FDA approval for facility ** Shares of Shivalik Rasayan SIVA.NS rise 13.1% to 639.9 rupees ** Agrochemicals and active pharma ingredients (API)-maker received U.S. FDA approval for its API facility in India's Gujarat state ** Stock eyes best day since July 3 ** SIVA down ~14% YTD; agrochemical rivals UPL U

Reuters - 4 days ago

ADNOC German deal is blueprint for Gulf takeovers

BREAKINGVIEWS-ADNOC German deal is blueprint for Gulf takeovers The author is a Reuters Breakingviews columnist. The opinions expressed are her own. By Karen Kwok LONDON, Oct 1 (Reuters Breakingviews) - Abu Dhabi National Oil Company (ADNOC) has succeeded where other Gulf buyers failed. After more than a year of negotiation, the Emirati oil giant led by Sultan al-Jaber has finally struck a deal to buy German chemical company Covestro 1COV.DE for 14.7 billion euros including debt.

Reuters - 4 days ago

Abu Dhabi's ADNOC to buy German chemicals firm Covestro for $16 bln

UPDATE 6-Abu Dhabi's ADNOC to buy German chemicals firm Covestro for $16 bln ADNOC to pay 62 euros per Covestro share, take on 3 bln in debt To buy additional 1.2 bln euros worth of new shares in Covestro Covestro shares jump 3.7% to a three-year high Deal could fuel debate over foreign takeovers of German firms Adds Covestro supervisory board's advisers in paragraph 26 By Ludwig Burger and Yousef Saba BERLIN/DUBAI Oct 1 (Reuters) - Abu Dhabi's ADNOC has struck a deal to buy German chemicals mak

Reuters - 5 days ago

ADNOC nears $13 billion deal to buy Germany's Covestro, WSJ reports

UPDATE 1-ADNOC nears $13 billion deal to buy Germany's Covestro, WSJ reports Adds details in paragraph 2, background from paragraph 4 onward Sept 30 (Reuters) - Abu Dhabi National Oil Company (ADNOC) is likely to announce a $13 billion-plus deal for Germany's Covestro 1COV.DE as soon as this week unless an unexpected snag emerges, the Wall Street Journal reported on Monday, citing people familiar with the matter.

Reuters - 1 week ago

Bayer To Present Seven New Analyses From HF

BRIEF-Bayer To Present Seven New Analyses From FINEARTS-HF Sept 27 (Reuters) - BAYER AG BAYGn.DE : TO PRESENT SEVEN NEW ANALYSES FROM FINEARTS-HF EXAMINING BENEFITS OF FINERENONE ACROSS A BROAD SPECTRUM OF HIGH-RISK HEART FAILURE PATIENTS Further company coverage: [BAYGn.DE] (Gdansk Newsroom)

Reuters - 1 week ago

Bayer's Bemdaneprocel For Parkinson's Disease Shows Positive Data At 24-Months

BRIEF-Bayer's Bemdaneprocel For Parkinson's Disease Shows Positive Data At 24-Months Sept 27 (Reuters) - BAYER AG BAYGn.DE : BLUEROCK THERAPEUTICS' INVESTIGATIONAL CELL THERAPY BEMDANEPROCEL FOR PARKINSON'S DISEASE SHOWS POSITIVE DATA AT 24-MONTHS DATA FROM PHASE 1 EXPDITE TRIAL CONTINUE TO SHOW A FAVORABLE SAFETY PROFILE IN ALL 12 PARTICIPANTS IN

Reuters - 1 week ago

Finland's Orion eyes US sales boost with blockbuster prostate cancer drug

Finland's Orion eyes US sales boost with blockbuster prostate cancer drug By Anne Kauranen HELSINKI, Sept 26 (Reuters) - Finnish drugmaker Orion ORNBV.HE wants to boost sales in the United States on the back of the success of its prostate cancer drug Nubeqa, which it is developing jointly with German partner Bayer BAYGn.DE , Orion's chief executive Liisa Hurme told Reuters.

Reuters - 1 week ago

Bayer Co.Lab Shanghai Opens As Part Of Global Expansion Of Life Science Incubator Network

BRIEF-Bayer Co.Lab Shanghai Opens As Part Of Global Expansion Of Life Science Incubator Network Sept 26 (Reuters) - BAYER AG BAYGn.DE : BAYER CO.LAB SHANGHAI OPENS AS PART OF GLOBAL EXPANSION OF LIFE SCIENCE INCUBATOR NETWORK AIMED AT FOSTERING OPEN COLLABORATION WITHIN BIOTECHNOLOGY ECOSYSTEM INAUGURATION OF ITS NEW LIFE SCIENCE INCUBATOR, BAYER C

Reuters - 1 week ago

BASF targets partial listing of agriculture division

UPDATE 2-BASF targets partial listing of agriculture division Adds CEO remarks in paragraphs 3 and 9 FRANKFURT, Sept 25 (Reuters) - BASF BASFn.DE is planning a partial listing of its agricultural business because the stock market is underestimating the unit's earnings prospects within the group, the German chemicals giant's new CEO told staff on Wednesday.

Reuters - 1 week ago

Bayer: AskBio To Collaborate With Belief BioMed

BRIEF-Bayer: AskBio To Collaborate With Belief BioMed Sept 25 (Reuters) - BAYER AG BAYGn.DE : ASKBIO TO COLLABORATE WITH BELIEF BIOMED TO EXPLORE POTENTIAL OF NEW GENE THERAPIES Further company coverage: [BAYGn.DE] (Gdansk Newsroom)

Reuters - 1 week ago

Jefferies hikes Orion to 'buy' on better Nubeqa sales forecast

BUZZ-Jefferies hikes Orion to 'buy' on better Nubeqa sales forecast ** Jefferies raises the Finnish drugmaker Orion ORNBV.HE to "buy" from "hold" driven by the increased estimates for peak sales of its prostate cancer drug Nubeqa ** Broker hikes its peak sales estimate for Nubequa, which was developed jointly by Orion and Bayer BAYGn.DE , to EUR 1.

Reuters - 2 weeks ago

Firms including Amazon to buy $180 million in carbon credits from namesake rainforest

UPDATE 1-Firms including Amazon to buy $180 million in carbon credits from namesake rainforest LEAF's first deal in the Amazon rainforest Para state to allocate proceeds to Indigenous and local communities Amazon, Bayer, BCG, Capgemini, H&M, Walmart to buy 5 million credits at $15 each Updates with official announcement at climate week By Jake Spring SAO PAULO, Sept 24 (Reuters) - Amazon AMZN.O and other companies have agreed to buy carbon offset credits that will support the conservation of its

Reuters - 2 weeks ago

Firms including Amazon to buy $180 million in carbon credits from namesake rainforest

CORRECTED-Firms including Amazon to buy $180 million in carbon credits from namesake rainforest Changes name of purchaser in paragraph 8 to Walmart Foundation By Jake Spring SAO PAULO, Sept 24 (Reuters) - Amazon AMZN.O and other companies have agreed to buy carbon offset credits that will support the conservation of its namesake rainforest in the Brazilian state of Para, in a deal valued at around $180 million.

Reuters - 2 weeks ago

Bayer And Care To Translate AB Announce Partnership To Improve Multilingual Access To Health Information For Patients With Hemophilia

BRIEF-Bayer And Care To Translate AB Announce Partnership To Improve Multilingual Access To Health Information For Patients With Hemophilia Sept 24 (Reuters) - BAYER AG BAYGn.DE : BAYER AG - AND CARE TO TRANSLATE AB ANNOUNCE STRATEGIC PARTNERSHIP TO IMPROVE MULTILINGUAL ACCESS TO HEALTH INFORMATION FOR PATIENTS WITH HEMOPHILIA BAYER AG - IS ENTERIN

Reuters - 2 weeks ago

European companies cut jobs as economy sputters

FACTBOX-European companies cut jobs as economy sputters Adds Northvolt Sept 23 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some of the layoffs announced since the start of June: BANKS * DNB DNB.OL : The Norwegian lender said on Sept. 10 it would cut the equivalent of 500 full-time jobs over the next six months, as it prepares for lower interest rates and tougher competition ahead.

Reuters - 2 weeks ago

Coca-Cola plans to invest $1 billion in Nigeria operations, presidency says

Coca-Cola plans to invest $1 billion in Nigeria operations, presidency says ABUJA, Sept 19 (Reuters) - Coca-Cola plans to invest $1 billion in its Nigeria operations over the next five years, the country's presidency said after a meeting between President Bola Tinubu and senior executives of the soft drinks maker on Thursday. Tinubu met John Murphy, president and chief financial officer of Coca‑Cola KO.N , Zoran Bogdanovic, CEO of Coca-Cola HBC CCH.L - one of Coca-Cola's many bottlers worldwid

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

BayerAG

News

Conditions

Popular Assets

XM Live Chat